Scleroderma Insights

UVA1 Phototherapy's Role in Managing Scleroderma Skin Symptoms

Top Stories

Latest Research

Research on scleroderma highlights that certain factors significantly increase the likelihood of developing this condition. Identifying these risk factors is crucial for understanding why some individuals are more prone to scleroderma. By focusing on these factors, researchers aim to develop better strategies for early detection and management, potentially leading to improved outcomes for those affected.

Further research is needed to fully understand these risk factors and their contribution to scleroderma's development. This ongoing investigation could lead to more effective treatments and better patient care. The study's findings emphasize the importance of continued research in this area, as noted by Navaneeth and Karthikeyan (2025).

Clinical Trials

This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Participants With Immune-Mediated Diseases (Ntrust-2)
Study Type
Phase I
Location
United States
Age Range
18 - 65 Years
Enrollment
72
A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease
Study Type
Phase I
Location
United States
Age Range
18+ Years
Enrollment
48
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Study Type
Phase III
Location
18 countries
Age Range
18+ Years
Enrollment
300
An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
Study Type
Interventional
Location
China
Age Range
18+ Years
Enrollment
18

Community News

Upcoming Events

MAY
03
Scleroderma patient education conference In Person Scleroderma Foundation of Greater Chicago • Chicago, IL